Ksudiram Naskar
Overview
Explore the profile of Ksudiram Naskar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Das P, Paik D, Naskar K, Chakraborti T
Microbes Infect
. 2017 Oct;
20(1):37-47.
PMID: 28970116
This study is aimed to evaluate the protective effect of L. donovani intracellular serine protease (SP-Ld) in combination with Freund's adjuvant and liposomal formulations against experimental visceral leishmaniasis (VL). The...
2.
Basu J, Mookerjee A, Banerjee R, Saha M, Singh S, Naskar K, et al.
Antimicrob Agents Chemother
. 2007 Dec;
52(3):1080-93.
PMID: 18056276
The emergence of antimony (Sb) resistance has jeopardized the treatment of visceral leishmaniasis in various countries. Previous studies have considered the part played by leishmanial parasites in antimony resistance, but...
3.
Basu J, Mookerjee A, Sen P, Bhaumik S, Sen P, Banerjee S, et al.
Antimicrob Agents Chemother
. 2006 Apr;
50(5):1788-97.
PMID: 16641451
Pentavalent antimony complexes, such as sodium stibogluconate and sodium antimony gluconate (SAG), are still the first choice for chemotherapy against various forms of leishmaniasis, including visceral leishmaniasis, or kala-azar. Although...